Microba Life Sciences Limited (ASX:MAP)

Dr Luke Reid
Market Cap (AUD): 72.42M
Sector: Health Care
Last Trade (AUD): 0.32 +0 (+0%)
Tab Bar

1. About

Microba Life Sciences Limited (ASX:MAP) is a precision microbiome science company powering medical innovation to transform human health.

The Company believes comprehensive and precise measurement of the human gut microbiome is required to drive innovation in medical care. Through its powerful analysis and discovery platforms, Microba Life Sciences is identifying novel microbiome-derived therapeutics and new diagnostic tools to advance medicine.

The Company's growing team is built on a foundation of scientific and technical excellence and a drive to discover ever-deeper insights into the relationships between gut microorganisms and health. Microba is continually increasing and refining the precision of its analysis, and believes in working with international partners who share its passion and scientific rigour to fast-track these new advances.

In short, Microba is transforming human health by leading life-changing microbiome discoveries based on ever more precise analysis of the microbiome.

2. Business model

3. Strategy

4. Markets

5. Competition

6. History

7. Team

8. Financials

9. Risk